Alto Neuroscience, Stock Buy Hold or Sell Recommendation
| ANRO Stock | 4.31 0.22 5.38% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Alto Neuroscience, is 'Strong Sell'. The recommendation algorithm takes into account all of Alto Neuroscience,'s available fundamental, technical, and predictive indicators you will find on this site.
Check out Alto Neuroscience, Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Alto Stock, please use our How to Invest in Alto Neuroscience, guide. In addition, we conduct extensive research on individual companies such as Alto and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Alto Neuroscience,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Alto |
Execute Alto Neuroscience, Buy or Sell Advice
The Alto recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Alto Neuroscience,. Macroaxis does not own or have any residual interests in Alto Neuroscience, or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Alto Neuroscience,'s advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Excited | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Alto Neuroscience, Trading Alerts and Improvement Suggestions
| Alto Neuroscience, generated a negative expected return over the last 90 days | |
| Alto Neuroscience, has high historical volatility and very poor performance | |
| Net Loss for the year was (36.3 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Alto Neuroscience, generates negative cash flow from operations | |
| Alto Neuroscience, has a frail financial position based on the latest SEC disclosures | |
| Over 75.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Board of Trustees of The Leland Stanford Junior University Sells 264,273 Shares of Alto Neuroscience, Inc. |
Alto Neuroscience, Returns Distribution Density
The distribution of Alto Neuroscience,'s historical returns is an attempt to chart the uncertainty of Alto Neuroscience,'s future price movements. The chart of the probability distribution of Alto Neuroscience, daily returns describes the distribution of returns around its average expected value. We use Alto Neuroscience, price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Alto Neuroscience, returns is essential to provide solid investment advice for Alto Neuroscience,.
| Mean Return | -0.5 | Value At Risk | -7.02 | Potential Upside | 7.14 | Standard Deviation | 9.89 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Alto Neuroscience, historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Alto Neuroscience, Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Alto Neuroscience, or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Alto Neuroscience,'s price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Alto stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1 | |
β | Beta against Dow Jones | 4.06 | |
σ | Overall volatility | 9.99 | |
Ir | Information ratio | -0.06 |
Alto Neuroscience, Volatility Alert
Alto Neuroscience, is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Alto Neuroscience,'s stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Alto Neuroscience,'s stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Alto Neuroscience, Fundamentals Vs Peers
Comparing Alto Neuroscience,'s fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Alto Neuroscience,'s direct or indirect competition across all of the common fundamentals between Alto Neuroscience, and the related equities. This way, we can detect undervalued stocks with similar characteristics as Alto Neuroscience, or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Alto Neuroscience,'s fundamental indicators could also be used in its relative valuation, which is a method of valuing Alto Neuroscience, by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Alto Neuroscience, to competition |
| Fundamentals | Alto Neuroscience, | Peer Average |
| Current Valuation | 184.12 M | 16.62 B |
| Shares Outstanding | 26.96 M | 571.82 M |
| Shares Owned By Insiders | 13.11 % | 10.09 % |
| Shares Owned By Institutions | 75.03 % | 39.21 % |
| Number Of Shares Shorted | 3.06 M | 4.71 M |
| Price To Book | 2.04 X | 9.51 X |
| EBITDA | (34.56 M) | 3.9 B |
| Net Income | (36.3 M) | 570.98 M |
| Total Debt | 151.46 M | 5.32 B |
| Book Value Per Share | 6.67 X | 1.93 K |
| Cash Flow From Operations | (33.45 M) | 971.22 M |
| Short Ratio | 11.82 X | 4.00 X |
| Earnings Per Share | (1.85) X | 3.12 X |
| Target Price | 31.5 | |
| Market Capitalization | 367.18 M | 19.03 B |
| Total Asset | 86.63 M | 29.47 B |
| Retained Earnings | (76.97 M) | 9.33 B |
| Working Capital | 79.78 M | 1.48 B |
| Net Asset | 86.63 M |
Note: Acquisition by Savitz Adam of 10681 shares of Alto Neuroscience, at 12.53 subject to Rule 16b-3 [view details]
Alto Neuroscience, Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Alto . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Alto Neuroscience, Buy or Sell Advice
When is the right time to buy or sell Alto Neuroscience,? Buying financial instruments such as Alto Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Alto Neuroscience, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Semiconductor Thematic Idea Now
Semiconductor
Companies involved in production of semiconductor and semiconductor materials. The Semiconductor theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Semiconductor Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Alto Neuroscience, Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Alto Stock, please use our How to Invest in Alto Neuroscience, guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alto Neuroscience,. If investors know Alto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alto Neuroscience, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.85) |
The market value of Alto Neuroscience, is measured differently than its book value, which is the value of Alto that is recorded on the company's balance sheet. Investors also form their own opinion of Alto Neuroscience,'s value that differs from its market value or its book value, called intrinsic value, which is Alto Neuroscience,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alto Neuroscience,'s market value can be influenced by many factors that don't directly affect Alto Neuroscience,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alto Neuroscience,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Alto Neuroscience, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alto Neuroscience,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.